N'-(5-Bromo-2-fluorobenzylidene)-4,5-dihydro-1H-benzo[g]indazole-3-carbohydrazide

Catalog No. :
ACZCZO610
CAS No. :
303106-10-7
Molecular Formula :
C19H14BrFN4O
Molecular Weight :
413.25

IUPAC Name:(E)-N'-(5-bromo-2-fluorobenzylidene)-4,5-dihydro-2H-benzo[g]indazole-3-carbohydrazide

N'-(5-Bromo-2-fluorobenzylidene)-4,5-dihydro-1H-benzo[g]indazole-3-carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-(5-Bromo-2-fluorobenzylidene)-4,5-dihydro-1H-benzo[g]indazole-3-carbohydrazide
IUPAC Name(E)-N'-(5-bromo-2-fluorobenzylidene)-4,5-dihydro-2H-benzo[g]indazole-3-carbohydrazide
MDL No.MFCD02075998
Molecular FormulaC19H14BrFN4O
Molecular Weight413.25
SMILESO=C(C1=NNC2=C1CCC3=CC=CC=C32)N/N=C/C4=CC(Br)=CC=C4F
InChI KeyNWOJMBCJXPANOQ-LSHDLFTRSA-N
SynonymN-[(E)-(5-bromo-2-fluorophenyl)methylideneamino]-4,5-dihydro-2H-benzo[g]indazole-3-carboxamide;1H-Benz[g]indazole-3-carboxylic acid, 4,5-dihydro-, 2-[(5-bromo-2-fluorophenyl)methylene]hydrazide;N'-(5-BR-2-FLUOROBENZYLIDENE)-4,5-DIHYDRO-1H-BENZO(G)INDAZOLE-3-CARBOHYDRAZIDE;N'-(5-BR-2-FLUOROBENZYLIDENE)-4,5-DIHYDRO-1H-BENZO(G)INDAZOLE-3-CARBOHYDRAZIDE
CAS No.303106-10-7

Synthetic Route by SureRoute

1. ACZCZO610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGEY783 route compound structure diagram
    ACPGEY78393777-26-5 In Stock
  4. Then
  5. ACZCZO610 route product structure diagram
    ACZCZO610303106-10-7
Inquiry

2. ACZCZO610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCZO610 route product structure diagram
    ACZCZO610303106-10-7
Inquiry

Comments (0)